Pebblebrook's CEO Bought 40,000 Shares Last Month. The Analysts Just Caught Up.
Pebblebrook's stock is up 60% this year, the CEO was buying shares at $17 while analysts still had "Hold" ratings, and Q2 earnings land July 28. The gap between insider conviction and Street consensus tells you more than either number alone.
Jon Bortz bought 40,000 shares of his own company on June 10 and 11 at roughly $17.50 per share. Three weeks later, Truist raised its target to $22 and the stock is trading above $19. That's a 26% implied return the CEO priced before the Street did.
Let's decompose what happened in Q1. Same-property EBITDA hit $82.2 million, up 27.6% year over year, beating the high end of their own outlook by $8.2 million. Adjusted FFO doubled to $0.32 per diluted share. San Francisco RevPAR jumped 44.5%. Los Angeles was up 31.5%. These aren't gradual recovery numbers. These are snapback numbers from markets that were left for dead 18 months ago. Revenue came in at $343.8 million against a $326.5 million consensus. The beat wasn't noise. It was $17 million of revenue the Street didn't model.
The balance sheet tells a quieter story that matters more. Net debt to trailing EBITDA dropped from 5.9x at year-end to 5.5x by March 31. They sold the Chamberlain West Hollywood for $43.5 million in May (that's roughly $580K per key on a 75-key boutique, which tells you what LA lifestyle assets still command). CapEx guidance is $65-75 million for the year, which on a 10,900-room portfolio works out to roughly $6,400 per key. That's maintenance-plus territory, not transformation capital. The major redevelopment cycle is behind them. Now they're harvesting.
Here's what the consensus "Hold" rating from 15 analysts actually means: most of them set their targets when PEB was a $12 stock with 6x leverage and uncertain urban recovery. The company moved. The models didn't. When you have a CEO buying stock at $17.50 and a sell-side target averaging $16.06, one of them is wrong. Insider purchases aren't marketing (they file with the SEC). Analyst targets are updated quarterly if you're lucky. The information asymmetry here isn't subtle.
The Q2 report on July 28 will answer one question: was Q1 a snapback or a trend? The raised full-year outlook (same-property RevPAR growth of 3-5%, midpoint up 75 basis points) suggests management sees durability. New supply in their markets is running at roughly 0.5% for 2026. A portfolio of 43 upper-upscale and resort properties in supply-constrained urban markets, with leverage coming down and a CEO buying stock... the $0.01 quarterly dividend is the only number here that looks wrong. That's a conversation for the July call.
Here's what matters if you're an asset manager or owner looking at upper-upscale urban exposure right now. Pebblebrook's San Francisco and LA numbers aren't just company-specific... they're market-recovery signals. If you own or manage in those markets, benchmark your Q1 against a 44.5% SF RevPAR gain and a 31.5% LA gain. If you're lagging those numbers, the problem isn't the market... it's your property. And if you're evaluating acquisitions in supply-constrained urban markets, look at where the CEO is putting his own money versus where the analysts are putting their targets. Insider conviction ahead of Street consensus is a pattern I've seen before. It doesn't guarantee anything, but I'd rather follow the person with skin in the game than the person updating a spreadsheet from a desk. Bring this to your investment committee before the Q2 print on July 28... not after.